The Patent Finder

Terms ending in 2034

CSL Behring GmbH

Every in-force patent on CSL Behring GmbH's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,534,029Method of Purifying Proteins
In force
 · High confidence
CSL Behring AGIn forceHigh confidence
US 10,286,047Treatment and Prevention of Remote Ischemia-Reperfusion Injury
In force
 · Medium confidence
CSL Behring GmbH and Universitaet BernIn forceMedium confidence
US 10,973,891Treatment and Prevention of Remote Ischemia-Reperfusion Injury
In force
 · High confidence
CSL Behring GmbH and Universitaet BernIn forceHigh confidence
US 10,221,233Compositions Comprising Secretory-Like Immunoglobulins
In force
 · High confidence
CSL Behring AGIn forceHigh confidence
US 10,441,631Therapeutic Agent for Amniotic Fluid Embolism
In force
 · High confidence
CSL Behring GmbHIn forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited